- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GENPHARMASEC's Board has approved key corporate actions, including setting the virtual Annual General Meeting (AGM) and its e-voting schedule. The Board also approved the Director's Report and Annual Report for the last financial year. A revision in the Whole Time Director & CFO's remuneration was approved. M/s. Bilimoria Mehta & Co. were appointed as the new Statutory Auditors for a five-year term, replacing the outgoing firm. These changes, along with certain material related party transactions, will require shareholder approval at the upcoming AGM.